Real-time surveillance on every dilution mechanism that destroys small-cap stock prices: shelf programs, ATM offerings, PIPE deals, new capital raises, warrant exercises, toxic note structures, and reverse split triggers. Coverage spans 7,300+ tickers with AI-scored dilution severity ratings, historical offering frequency, and same-day alerts the moment a new signal hits. Most traders find out about dilution when their position is already down 30%. DilutionWatch users find out first.

A complete biotech intelligence platform covering every FDA decision date, clinical trial readout, and pipeline catalyst across 950+ publicly traded companies. Each upcoming event is AI-scored for historical outcome probability, giving you a quantified edge on binary trades before the calendar date arrives. Screen by indication, trial phase, PDUFA timing, or cash runway. Integrated insider buying signals flag when management is loading up ahead of key dates. The FDA calendar, finally made tradeable.

A consolidated intelligence feed that normalizes every insider transaction disclosure, congressional stock trade, institutional position change, dark pool block print, and whale accumulation pattern into one ranked signal stream. Filter by conviction tier, dollar threshold, cluster frequency, sector, or market cap. When multiple smart-money signals align on the same ticker simultaneously, StonkWhisper surfaces the convergence — before it shows up in volume or price.

A searchable map of 121,000+ supplier, customer, and partner relationships across publicly traded companies. Enter any ticker and trace its full dependency graph — who supplies it, who it supplies, and what percentage of revenue is concentrated in each relationship. When a major partner issues a profit warning, announces layoffs, or loses a contract, ChainSifter lets you identify the small-cap ripple effects before they register in price. The supply chain edge hiding in plain sight.